These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

296 related articles for article (PubMed ID: 29141361)

  • 1. [Effect of probucol on preventing contrast-induced nephropathy in patients undergoing percutaneous coronary intervention].
    Suo XQ; Yang SC; Ma ZH; Sun TT; Zhang WY; Cong HL; Lin WH; Lu CZ; Tian FS; Fu NK
    Zhonghua Yi Xue Za Zhi; 2017 Nov; 97(41):3234-3238. PubMed ID: 29141361
    [No Abstract]   [Full Text] [Related]  

  • 2. The efficacy of probucol combined with hydration in preventing contrast-induced nephropathy in patients with coronary heart disease undergoing percutaneous coronary intervention: a multicenter, prospective, randomized controlled study.
    Fu N; Yang S; Zhang J; Zhang P; Liang M; Cong H; Lin W; Tian F; Lu C
    Int Urol Nephrol; 2018 Jan; 50(1):105-112. PubMed ID: 29071556
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Effects of probucol on contrast-induced acute kidney injury in patients undergoing percutaneous coronary intervention.
    Wang Y; Shi Y; Xu X; Ge W; Yang S; Lu C
    Medicine (Baltimore); 2019 Jun; 98(25):e16049. PubMed ID: 31232940
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Neutrophil gelatinase-associated lipocalin (NGAL) for the early detection of contrast-induced nephropathy after percutaneous coronary intervention.
    Liebetrau C; Gaede L; Doerr O; Blumenstein J; Rixe J; Teichert O; Willmer M; Weber M; Rolf A; Möllmann H; Hamm C; Nef H
    Scand J Clin Lab Invest; 2014 Mar; 74(2):81-8. PubMed ID: 24304491
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [Association between high-sensitivity C-reactive protein and contrast-induced nephropathy after primary percutaneous coronary intervention].
    He YT; Tan N; Liu YH; Chen SQ; Liu Y; Huang SJ; Yang DH; Ye P; Ran P
    Zhonghua Xin Xue Guan Bing Za Zhi; 2013 May; 41(5):394-8. PubMed ID: 24021122
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Efficacy of alprostadil in preventing contrast-induced nephropathy in patients undergoing percutaneous coronary intervention: A multicenter prospective randomized controlled trial.
    Liang M; Yang S; Fu N; Lu C; Tian F; Xing X; Lin W; Liu J
    Catheter Cardiovasc Interv; 2018 Mar; 91(4):742-750. PubMed ID: 29024304
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Predict value of monitoring changes of urinary neutrophil gelatinase-associated lipocalin and kidney injury molecule-1 after coronary angiography and percutaneous coronary intervention on early diagnosis of contrast-induced nephropathy].
    Wang L; Pu X
    Zhonghua Xin Xue Guan Bing Za Zhi; 2014 Apr; 42(4):301-4. PubMed ID: 24924456
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Effects of remote ischemic preconditioning on contrast induced nephropathy after percutaneous coronary intervention in patients with acute coronary syndrome.
    Zhou F; Song W; Wang Z; Yin L; Yang S; Yang F; Song Z; Song Y; Zhang H; Qiao F; Zhang Z
    Medicine (Baltimore); 2018 Jan; 97(2):e9579. PubMed ID: 29480853
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Preventive effect of oral nicorandil on contrast-induced nephropathy in patients with renal insufficiency undergoing elective cardiac catheterization.
    Fan Y; Wei Q; Cai J; Shi Y; Zhang Y; Yao L; Wang X; Lin S; Li Y; Lv J; Zhou B; Du R
    Heart Vessels; 2016 Nov; 31(11):1776-1782. PubMed ID: 26874946
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The role of probucol preventing contrast-induced nephropathy in patients undergoing invasive coronary procedures - Systematic review and meta-analysis of randomized controlled trials.
    Pranata R; Yonas E; Vania R; Lukito AA
    Turk Kardiyol Dern Ars; 2021 Jan; 49(1):51-59. PubMed ID: 33390574
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Safety and efficacy of anisodamine on prevention of contrast induced nephropathy in patients with acute coronary syndrome.
    Wang YB; Fu XH; Gu XS; Wang XC; Zhao YJ; Hao GZ; Jiang YF; Fan WZ; Wu WL; Li SQ; Xue L
    Chin Med J (Engl); 2012 Mar; 125(6):1063-7. PubMed ID: 22613532
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Effects of Dapagliflozin on contrast-induced acute kidney injury in patients with type 2 diabetes mellitus underwent percutaneous coronary intervention].
    Yang SC; Ma YF; Zhang P; Cong HL; Fu NK
    Zhonghua Yi Xue Za Zhi; 2024 Jun; 104(22):2059-2065. PubMed ID: 38858216
    [No Abstract]   [Full Text] [Related]  

  • 13. Elevated high-sensitivity C-reactive protein combined with procalcitonin predicts high risk of contrast-induced nephropathy after percutaneous coronary intervention.
    Gu G; Yuan X; Zhou Y; Liu D; Cui W
    BMC Cardiovasc Disord; 2019 Jun; 19(1):152. PubMed ID: 31234798
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Renal Protective Effect of Probucol in Rats with Contrast-Induced Nephropathy and its Underlying Mechanism.
    Wang N; Wei RB; Li QP; Yang X; Li P; Huang MJ; Wang R; Cai GY; Chen XM
    Med Sci Monit; 2015 Sep; 21():2886-92. PubMed ID: 26408630
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Association between high sensitivity C-reactive protein and contrast induced acute kidney injury in patients with acute coronary syndrome undergoing percutaneous coronary intervention: impact of atorvastatin].
    Su JZ; Xue Y; Cai WQ; Huang QY; Chai DJ; Chen GL; Wang FB; Chen XP; Zhang DS
    Zhonghua Xin Xue Guan Bing Za Zhi; 2011 Sep; 39(9):807-11. PubMed ID: 22321227
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Values of serum neutrophil gelatinase-associated lipocalin and cystatin C after percutaneous coronary intervention for early diagnosis of contrast-induced nephropathy.
    Luo P; Ao W; Xiang D; Wang J; Liu J
    Afr Health Sci; 2023 Sep; 23(3):593-598. PubMed ID: 38357177
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Insulin Resistance Increases the Risk of Contrast-Induced Nephropathy in Patients Undergoing Elective Coronary Intervention.
    Li Y; Liu Y; Shi D; Yang L; Liang J; Zhou Y
    Angiology; 2016 Feb; 67(2):139-45. PubMed ID: 25843952
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [The value of urinary neutrophil gelatinase-associated lipocalin for early diagnosis of contrast-induced nephropathy].
    You W; Qi CL; Ye F; Huang SL; Xie DJ; Wu ZM; Huang K; Chen KL; Huang TY; Chen SL
    Zhonghua Xin Xue Guan Bing Za Zhi; 2016 Dec; 44(12):1024-1029. PubMed ID: 28056233
    [No Abstract]   [Full Text] [Related]  

  • 19. Cystatin C, but not urinary or serum NGAL, may be associated with contrast induced nephropathy after percutaneous coronary invasive procedures: A single center experience on a limited number of patients.
    Cecchi E; Avveduto G; D'Alfonso MG; Terreni A; Gelera E; Caldini A; Giglioli C
    Acta Med Acad; 2017 May; 46(1):34-43. PubMed ID: 28605926
    [TBL] [Abstract][Full Text] [Related]  

  • 20. B-type natriuretic peptide for prevention of contrast-induced nephropathy in patients with heart failure undergoing primary percutaneous coronary intervention.
    Zhang J; Fu X; Jia X; Fan X; Gu X; Li S; Wu W; Fan W; Su J; Hao G; Jiang Y; Xue L
    Acta Radiol; 2010 Jul; 51(6):641-8. PubMed ID: 20438292
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 15.